Christopher Paul German - Feb 14, 2025 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Corporate Controller & CAO
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Christopher Paul German
Stock symbol
RYTM
Transactions as of
Feb 14, 2025
Transactions value $
-$36,335
Form type
4
Date filed
2/19/2025, 09:45 PM
Previous filing
Apr 3, 2024
Next filing
Mar 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +1.81K +201.22% 2.71K Feb 16, 2025 Direct F1, F2
transaction RYTM Common Stock Sale -$36.3K -635 -23.48% $57.22 2.07K Feb 19, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Award $0 +7.23K $0.00 7.23K Feb 14, 2025 Common Stock 7.23K Direct F1, F4
transaction RYTM Stock Options (Right to Buy) Award $0 +5.4K $0.00 5.4K Feb 14, 2025 Common Stock 5.4K $56.69 Direct F5
transaction RYTM Restricted Stock Units Options Exercise $0 -1.81K -25.01% $0.00 5.42K Feb 16, 2025 Common Stock 1.81K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 Includes 103 additional shares acquired under the Issuer's Employee Stock Purchase Plan.
F3 The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
F4 The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.
F5 The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F6 The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney